Abstract
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Author(s): Harrington Amy, Williams LaVonn
Issue: Jul/Aug 2022 - Volume 26, Number 4
Page(s): 293-296
Download in electronic PDF format for $75
Abstract
Medications on the market for the treatment of arthritis are more commonly appropriate for adult arthritic patients. However, for patients with juvenile arthritis, a compounding pharmacist can prepare specialized medications for those patients who are in need of a specific dosage, or for those patients who require a different dosage form. Additionally, more than one active ingredient can be combined in pharmacy compounding to meet a specific patient’s needs. Compounded topical/transdermal preparations can provide customized medication options, which may not be commercially available, for pediatric patients with juvenile arthritis.
Related Keywords
- Amy Harrington
- juvenile arthritis
- topical preparations
- transdermal administration
- pediatric rheumatic disease
- autoimmune disorders
- autoinflammatory diseases
- inflammation
- anti-inflammatory agents
- nonsteroidal anti-inflammatory drugs
- NSAIDs
- corticosteroids
- disease-modifying antirheumatic drugs
- DMARDs
- biologic DMARDS
- tumor necrosis factor inhibitors
- medication adherence
Related Categories
- PAIN MANAGEMENT
- PEDIATRICS
- ALLERGY/IMMUNOLOGY/INFLAMMATION
- MUSCULOSKELETAL DISORDERS